Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Phosphorylation Site Page:
Ser1062 - INSR (human)

Site Information
AVKTVNEsASLRERI   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: INSR (mouse): S1052, INSR iso2 (human): (S1050), INSR (rat): (S1063)
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 451562

In vivo Characterization
Methods used to characterize site in vivo: [32P] bio-synthetic labeling (3), electrophoretic mobility shift (3), immunoprecipitation (2), mutation of modification site (2, 3), phosphopeptide mapping (3), western blotting (2)
Relevant cell line - cell type - tissue: 293 (epithelial) (2), CHO (fibroblast) [EphB1 (human), transfection] (3)

Controlled by
Regulatory protein: PKCB iso2 (human) (2), PKCH (human) (2)
Kinases, in vitro: PKCA (human) (3)
Treatments: phorbol_ester (3)

Downstream Regulation
Effects of modification on INSR: phosphorylation (2)



Coba MP, Turyn D, Peña C (2003) Synthesis and immunogenic properties of phosphopeptides related to the human insulin receptor. J Pept Res 61, 17-23
12472845   Curated Info


Strack V, et al. (2000) Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta. Diabetologia 43, 443-9
10819237   Curated Info


Liu F, Roth RA (1994) Identification of serines-1035/1037 in the kinase domain of the insulin receptor as protein kinase C alpha mediated phosphorylation sites. FEBS Lett 352, 389-92
7926007   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.